Epirubicin is an anthracycline chemotherapy agent used to treat breast cancer. It works by inhibiting DNA synthesis and inducing cell death in rapidly dividing cancer cells. Epirubicin is effective in managing breast cancer. Common side effects may include nausea and hair loss, but these usually resolve over time. In summary, Epirubicin is crucial for cancer treatment.
Epirubicin intercalates with DNA and inhibits topoisomerase II, preventing DNA replication and leading to apoptosis in cancer cells.